文献速递肺栓塞与肺血管病

美国慢性血栓栓塞性肺动脉高压登记研究:入组特征与1年随访结果

Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry: Enrollment Characteristics and 1-Year Follow-up.
PubMed 文献 · Chest · 2021-06-04

美国CTEPH登记研究纳入750例新诊断患者,比较手术与非手术患者的基线特征和1年结局。多数患者有急性肺栓塞史,诊断延迟中位10个月。PTE手术使肺血管阻力中位从6.9降至2.6 Wood单位,院内死亡率3.9%;1年时手术组WHO功能分级1-2级比例更高(82.9% vs 不可手术组48.2%和可手术未手术组56%,P<.001)。

要点

  • CTEPH患者诊断延迟常见(中位10个月),多数有急性肺栓塞史。
  • PTE手术可显著降低肺血管阻力,但院内死亡率为3.9%。
  • 手术组1年功能结局优于非手术组。

核心结论

  • 可手术与不可手术CTEPH患者临床特征存在差异,接受PTE手术者1年结局最佳。

研究设计与样本

  • 多中心、前瞻性、纵向、观察性登记研究,纳入2015-2018年新诊断(<6个月)CTEPH患者750例,随访至2019年。
  • 纳入标准要求右心导管证实平均肺动脉压≥25 mm Hg且影像学确认CTEPH。

主要发现

  • 87.9%患者报告急性肺栓塞史,诊断延迟中位10个月,入组时多数为WHO功能分级3级,平均肺动脉压中位44 mm Hg。
  • PTE手术使肺血管阻力中位从6.9降至2.6 Wood单位(P < .001),院内死亡率3.9%。
  • 1年随访时手术组WHO功能分级1或2级比例为82.9%,不可手术组为48.2%,可手术未手术组为56%(P < .001)。
  • 不可手术患者较手术患者年龄更大,较少肥胖、深静脉血栓史、非O型血或血栓形成倾向,更可能有COPD或癌症史。

临床怎么用

  • 对CTEPH患者应评估手术可操作性,PTE手术可改善血流动力学和1年功能状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The United States Chronic Thromboembolic Pulmonary Hypertension Registry (US-CTEPH-R) was designed to characterize the demographic characteristics, evaluation, clinical course, and outcomes of surgical and nonsurgical therapies for patients with chronic thromboembolic pulmonary hypertension. RESEARCH QUESTION: What are the differences in baseline characteristics and 1-year outcomes between operated and nonoperated subjects? STUDY DESIGN AND METHODS: This study describes a multicenter, prospective, longitudinal, observational registry of patients newly diagnosed (< 6 months) with CTEPH. Inclusion criteria required a mean pulmonary artery pressure ≥ 25 mm Hg documented by right heart catheterization and radiologic confirmation of CTEPH. Between 2015 and 2018, a total of 750 patients were enrolled and followed up biannually until 2019. RESULTS: Most patients with CTEPH (87.9%) reported a history of acute pulmonary embolism. CTEPH diagnosis delays were frequent (median, 10 months), and most patients reported World Health Organization functional class 3 status at enrollment with a median mean pulmonary artery pressure of 44 mm Hg. The registry cohort was subdivided into Operable patients undergoing pulmonary thromboendarterectomy (PTE) surgery (n = 566), Operable patients who did not undergo surgery (n = 88), and those who were Inoperable (n = 96). Inoperable patients were older than Operated patients; less likely to be obese; have a DVT history, non-type O blood group, or thrombophilia; and more likely to have COPD or a history of cancer. PTE resulted in a median pulmonary vascular resistance decline from 6.9 to 2.6 Wood units (P < .001) with a 3.9% in-hospital mortality. At 1-year follow-up, Operated patients were less likely treated with oxygen, diuretics, or pulmonary hypertension-targeted therapy compared with Inoperable patients. A larger percentage of Operated patients were World Health Organization functional class 1 or 2 at 1 year (82.9%) compared with the Inoperable (48.2%) and Operable/No Surgery (56%) groups (P < .001). INTERPRETATION: Differences exist in the clinical characteristics between patients who exhibited operable CTEPH and those who were inoperable, with the most favorable 1-year outcomes in those who underwent PTE surgery. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT02429284; URL: www.clinicaltrials.gov.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Kerr KM, Elliott CG, Chin K, et al. Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry: Enrollment Characteristics and 1-Year Follow-up. Chest. 2021. PMID: 34090871. doi:10.1016/j.chest.2021.05.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。